Liujing Xing, Ph.D., focuses her practice on patent prosecution, global portfolio strategy, and strategic counseling for clients in the pharmaceutical and biotechnology industries. She works closely with companies, investors, and research institutions to develop patent strategies that support product development, financing, partnering, and commercialization goals.
Liujing advises clients on building, strengthening, and managing patent portfolios across a range of complex life sciences technologies, including therapeutic antibodies and other biologics, small molecules, cell and gene therapies, gene-editing technologies, and molecular diagnostics and sequencing. Her practice includes U.S. and foreign patent prosecution, due diligence, patentability assessments, patent landscape reviews, freedom-to-operate counseling, and opinion work. She counsels emerging companies, private equity and venture capital firms, academic and research institutions, and established life sciences companies on patent issues arising throughout the product and company life cycle.
Liujing received her Ph.D. in developmental biology from Stanford University, where her doctoral research focused on cell signaling pathways and the molecular regulation of neural stem cells.
In addition to her legal practice, Liujing teaches patent prosecution as an adjunct faculty member at Boston University School of Law.
In her free time, Liujing enjoys running and spending time with her family.
